Folger Nolan Fleming Douglas Capital Management Inc. trimmed its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 11.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,576 shares of the medical instruments supplier’s stock after selling 3,065 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $878,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. SOA Wealth Advisors LLC. raised its position in shares of DENTSPLY SIRONA by 26,666.7% in the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 800 shares in the last quarter. Parkside Financial Bank & Trust increased its position in DENTSPLY SIRONA by 33.8% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,224 shares of the medical instruments supplier’s stock valued at $43,000 after buying an additional 309 shares in the last quarter. Dixon Hughes Goodman Wealth Advisors LLC acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at about $79,000. Wahed Invest LLC acquired a new position in DENTSPLY SIRONA during the 4th quarter valued at about $145,000. Finally, Covestor Ltd increased its position in DENTSPLY SIRONA by 97.8% during the 1st quarter. Covestor Ltd now owns 3,198 shares of the medical instruments supplier’s stock valued at $157,000 after buying an additional 1,581 shares in the last quarter. 96.00% of the stock is owned by institutional investors.
DENTSPLY SIRONA Price Performance
Shares of DENTSPLY SIRONA stock traded up $0.02 during mid-day trading on Friday, reaching $29.57. 116,738 shares of the stock traded hands, compared to its average volume of 2,151,028. The business has a 50-day moving average of $34.52 and a 200 day moving average of $39.22. DENTSPLY SIRONA Inc. has a fifty-two week low of $29.41 and a fifty-two week high of $61.18. The stock has a market capitalization of $6.37 billion, a PE ratio of 17.52, a PEG ratio of 2.50 and a beta of 0.92. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38.
DENTSPLY SIRONA Dividend Announcement
Analyst Ratings Changes
XRAY has been the topic of several recent analyst reports. The Goldman Sachs Group reduced their target price on DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating on the stock in a research report on Thursday, July 21st. Piper Sandler dropped their price target on DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th. Morgan Stanley dropped their price target on DENTSPLY SIRONA from $48.00 to $44.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 20th. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Monday, August 15th. Finally, UBS Group upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and dropped their price target for the company from $58.00 to $47.00 in a research note on Wednesday, June 1st. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus target price of $48.11.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- Why Does Tesla Stock Remain Resilient?
- Is Costco’s Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.